4//SEC Filing
INKINE PHARMACEUTICAL CO INC 4
Accession 0001125282-05-003118
CIK 0000929547operating
Filed
Jun 12, 8:00 PM ET
Accepted
Jun 13, 7:13 PM ET
Size
7.9 KB
Accession
0001125282-05-003118
Insider Transaction Report
Form 4
HARRAL WILLIAM III
Director
Transactions
- Award
Common Stock (Right to Buy)
2005-06-08+17,000→ 17,000 totalExercise: $2.11Exp: 2015-06-07→ Common Stock (17,000 underlying) - Award
Common Stock (Right to Buy)
2005-06-08+36,000→ 36,000 totalExercise: $2.11Exp: 2015-06-07→ Common Stock (36,000 underlying)
Footnotes (2)
- [F1]On the transaction date, the reporting person was granted options to buy 17,000 shares of common stock. These options will become exercisable as follows: 5,667 on the transaction date, 5,667 one year after the transaction date and the remaining 5,666 two years after the transaction date.
- [F2]On the transaction date, the reporting person was granted options to buy 36,000 shares of common stock. These options will become exercisable one year after the transaction date.
Documents
Issuer
INKINE PHARMACEUTICAL CO INC
CIK 0000929547
Entity typeoperating
IncorporatedNY
Related Parties
1- filerCIK 0000929547
Filing Metadata
- Form type
- 4
- Filed
- Jun 12, 8:00 PM ET
- Accepted
- Jun 13, 7:13 PM ET
- Size
- 7.9 KB